Financials

  • Market Capitalization 5.7 M
  • Employee 19
  • Founded 1996
  • CEO N/A
  • Website bgmsglobal.com
  • Headquarter Delaware, United States
  • FIGI BBG000CT3XM2
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.16
Rapporto prezzo/fatturato
1.59

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4884
XTLB
XTL Biopharmaceuticals Ltd - American Depositary Shares
2.54 USD-1.55%-4.51%+1.60%+182.85%6.01 M USD
4894
PCSA
Processa Pharmaceuticals, Inc. - Common Stock
2.06 USD-3.29%-2.37%+0.49%-7.41%5.75 M USD
4900
LIMN
Liminatus Pharma, Inc. - Class A Common Stock
4.23 USD-3.86%-16.07%+3745.45%+43.39%5.68 M USD
4901
BTAI
BioXcel Therapeutics, Inc. - Common Stock
0.18 USD-75.00%-77.50%-77.22%-88.61%5.63 M USD